CytomX Therapeutics (CTMX) Capital Expenditures Growth (5y) (2019 - 2025)
CytomX Therapeutics (CTMX) Capital Expenditures Growth (5y) (2019 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 69,146.49 Bn | 69,146.20 Bn | - |
| 2 | Nanobiotix | 1,942.19 Bn | 1,942.13 Bn | - |
| 3 | Akari Therapeutics | 1,132.35 Bn | 1,132.35 Bn | - |
| 4 | BeOne Medicines | 475.42 Bn | 470.63 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 123.32 Bn | 116.08 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.80 Bn | 61.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 63.28 Bn | 63.28 Bn | - |
| 8 | Argenx Se | 56.67 Bn | 51.48 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 38.15 Bn | 38.15 Bn | - |
| 10 | CytomX Therapeutics | 606.27 Mn | 259.57 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 16.17% |
| Sep 30, 2025 | -16.69% |
| Jun 30, 2025 | -6.11% |
| Mar 31, 2025 | -35.29% |
| Dec 31, 2024 | -35.25% |
| Sep 30, 2024 | -61.95% |
| Jun 30, 2024 | 15.63% |
| Mar 31, 2024 | -42.53% |
| Dec 31, 2023 | 21.20% |
| Sep 30, 2023 | -65.51% |
| Jun 30, 2023 | 3.51% |
| Mar 31, 2023 | -34.26% |
| Dec 31, 2022 | 16.96% |
| Sep 30, 2022 | 48.38% |
| Jun 30, 2022 | -16.87% |
| Mar 31, 2022 | 26.19% |
| Dec 31, 2021 | -16.46% |
| Sep 30, 2021 | -28.44% |
| Jun 30, 2021 | 21.33% |
| Mar 31, 2021 | 24.60% |